Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

A deep learning system can accurately detect vision-threatening diabetic retinopathy, demonstrating specialist-level diagnostic performance.

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

Ophthalmologist , Vitreoretinal Surgeon, talks about how diabetic retinopathy is caused in patients with diabetes as well as treatment and management strategies.

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

The global Diabetic Retinopathy Market is estimated to be valued at USD 9,830 million in 2025 and is projected to reach USD 18,259.3 million by 2035, registering a compound annual growth rate (CAGR) ...

As the number of South Africans diagnosed with diabetes continues to increase, coupled with an ageing population, the ...

Objective To explore the risk factors of diabetic retinopathy (DR) and sight-threatening diabetic retinopathy (STDR) among Chinese patients with diabetes. Design, setting and participants A ...

Conclusions The algorithm reliably identifies patients at high risk of developing advanced stages of diabetic retinopathy, including preproliferative R2, active proliferative R3A and maculopathy M1.

About diabetic retinopathy Accounting for approximately 5% of all cases of visual impairment, diabetic retinopathy (DR) occurs when damage to the blood vessels and the formation of new blood vessels ...